Stock Earnings

Question 1

What are Kymera Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Kymera Therapeutics Inc has a total asset of $978, Net loss of $-223

Question 2

What are the key financial ratios for KYMR?

Accepted Answer

Kymera Therapeutics Inc's Current ratio is 6.88, has a Net margin is -474.46, sales per share of $0.62.

Question 3

How is Kymera Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Kymera Therapeutics Inc largest revenue segment is Small Molecule Therapeutics, at a revenue of 47,072,000 in the most earnings release.For geography, United States is the primary market for Kymera Therapeutics Inc, at a revenue of 47,072,000.

Question 4

Is Kymera Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Kymera Therapeutics Inc has a net loss of $-223

Question 5

Does Kymera Therapeutics Inc have any liabilities?

Accepted Answer

yes, Kymera Therapeutics Inc has liability of 142

Question 6

How many outstanding shares for Kymera Therapeutics Inc?

Accepted Answer

Kymera Therapeutics Inc has a total outstanding shares of 64.89

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	43	47	78	46	72	34
Revenue Growth (YoY)	-51%	-40%	70%	-36%	112%	1,600%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	67	63	55	43	36	18
Research & Development	304	240	189	164	137	62
Operating Expenses	372	303	244	208	173	80
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-295	-223	-146	-154	-100	-45
Income Tax Expense	--	--	--	--	--	--
Net Income	-295	-223	-146	-154	-100	-54
Net Income Growth	77%	53%	-5%	54%	85%	32%
Shares Outstanding (Diluted)	87.3	75.04	58.36	53.93	47.99	44.48
Shares Change (YoY)	15%	28.99%	8%	12%	8%	3%
EPS (Diluted)	-3.38	-2.98	-2.51	-2.87	-2.09	-1.23
EPS Growth	54%	18%	-12%	37%	70%	28%
Free Cash Flow	-230	-207	-137	-155	-130	79
Free Cash Flow Per Share	-2.63	-2.75	-2.34	-2.87	-2.7	1.77
Gross Margin	--	--	--	--	--	--
Operating Margin	-762.79%	-544.68%	-211.53%	-350%	-138.88%	-135.29%
Profit Margin	-686.04%	-474.46%	-187.17%	-334.78%	-138.88%	-158.82%
Free Cash Flow Margin	-534.88%	-440.42%	-175.64%	-336.95%	-180.55%	232.35%
EBITDA	-320	-249	-162	-159	-98	-45
EBITDA Margin	-744.18%	-529.78%	-207.69%	-345.65%	-136.11%	-132.35%
D&A For EBITDA	8	7	3	2	2	1
EBIT	-328	-256	-165	-161	-100	-46
EBIT Margin	-762.79%	-544.68%	-211.53%	-350%	-138.88%	-135.29%
Effective Tax Rate	--	--	--	--	--	--

Kymera Therapeutics Inc (KYMR) Price

KYMR Stock Price Chart

KYMR Income

Follow-Up Questions